apl. Prof. Dr. Peter Goebell

Medizinische Fakultät Urologische Klinik

Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review (2026) Ahrens M, Haanen J, Albiges L, Goupil MG, Boleti E, Gravis G, Fléchon A, et al. Journal article Leitlinien als evidenzbasierter Rahmen – Aktuelles für die Praxis (2026) Borkowetz A, Goebell P, Niegisch G Journal article Drug-Drug Interactions as a Challenge in the Monotherapy of Advanced or Metastatic Clear-Cell Renal Cell Carcinoma with VEGFR-Associated Tyrosine Kinase Inhibitors Arzneimittelinteraktionen als Herausforderung bei der Monotherapie des fortgeschrittenen oder metastasierten klarzelligen Nierenzellkarzinoms mit VEGFR-assoziierten Tyrosinkinase-Inhibitoren (2026) Reinbold H, Goebell P, Merseburger AS Journal article, Review article Perioperative therapy for muscle-invasive bladder cancer—current treatment concepts Leitlinie „Harnblasenkarzinom“ – was gibt es Neues? (2026) Niegisch G, Gakis G, Ohlmann CH, Knüchel-Clarke R, Beyersdorff D, Rick O, Golka K, et al. Journal article, Review article Effect of Recipient Variables on Transplant Survival Following Marginal Kidney Donation: Analysis of a Mate Kidney Cohort (2025) Androvitsanea A, Heller KM, Apel H, Kunath F, Goebell P, Wullich B, Rother U, et al. Journal article Results of the Prospective Randomized UroFollow Trial Comparing Marker-guided Versus Cystoscopy-based Surveillance in Patients with Low/Intermediate-risk Bladder Cancer (2025) Schmitz-Dräger B, Bismarck E, Roghmann F, von Landenberg N, Noldus J, Jahn D, Kernig K, et al. Journal article Improving quality of care for cancer patients through oncological second opinions in a Comprehensive Cancer Center: adherence to second-opinion therapy recommendations (2025) Schulmeyer C, Fasching P, Beckmann M, Häberle L, Golcher H, Goebell P, Pöschke P, Emons J Journal article Change of the guards—Looking back at Michael Droller: Visionary and supporter—The perspective of the International Bladder Cancer Network (2025) Schmitz-Dräger B, Grossmann HB, Goebell P, Kamat AM, Black PC Journal article Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma—Real-world data from the German research platform CARAT (2025) Goebell P, Bögemann M, Nusch A, Grünwald V, Müller L, von der Heyde E, Martens UM, et al. Journal article Androgenrezeptor-gerichtete Therapien – klinisch relevante Interaktionen vermeiden (2025) Lipp HP, Von Amsberg G, Merseburger AS, Rausch S, Schöning T, Klier J, Goebell P Journal article, Review article